Skip to content

Net Income at other companies

Pfizer logo
PfizerPFE
$2.69B-9.4%
Summit Therapeutics logo
Summit TherapeuticsSMMT
-$189.42M-201%
Exelixis logo
ExelixisEXEL
$210.47M+31.9%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-$453.82M-113%
Incyte logo
IncyteINCY
$303.33M+91.7%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s net income?
Nuvalent, Inc. (NUVL) reported net income of -$109.28M in Q1 2026.
How has Nuvalent, Inc.'s net income changed year-over-year?
Nuvalent, Inc.'s net income decreased by 29.2% year-over-year, from -$84.58M to -$109.28M.
What is the long-term trend for Nuvalent, Inc.'s net income?
Over 4 years (2021 to 2025), Nuvalent, Inc.'s net income has grown at a 74.1% compound annual growth rate (CAGR), from -$46.34M to -$425.4M.
What does net income mean?
The final profit or loss remaining after all expenses are paid.
How do you interpret net income?
Positive net income indicates a profitable period, while negative net income indicates a net loss.
How does net income compare across companies?
The most widely used metric for comparing overall financial success across all public companies.